Argent Trust Company’s Gilead Sciences GILD Stock Holding History

Argent Trust Company’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$1.14M	Sell	11,597 -92	-0.8%	-$10.2K	0.51%	59
2015 Q2	$1.37M	Sell	11,689 -105	-0.9%	-$11.5K	0.55%	57
2015 Q1	$1.16M	Buy	11,794 +4,867	+70%	+$494K	0.47%	68
2014 Q4	$653K	Sell	6,927 -5,659	-45%	-$585K	0.27%	94
2014 Q3	$1.34M	Sell	12,586 -110	-0.9%	-$10.8K	0.52%	64
2014 Q2	$1.05M	Buy	12,696 +3,885	+44%	+$302K	0.37%	79
2014 Q1	$624K	Buy	8,811 +390	+5%	+$30.6K	0.23%	92
2013 Q4	$632K	Sell	8,421 -157	-2%	-$10.9K	0.24%	91
2013 Q3	$540K	Hold	8,578	–	–	0.23%	89
2013 Q2	$439K	Buy	+8,578	New	+$447K	0.19%	95

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Argent Trust Company's GILD Position: Q3 2015 in Review

Argent Trust Company reduced its Gilead Sciences (GILD) stake by 0.79% in Q3 2015, selling an estimated $10.2K and leaving 11,597 shares worth $1.14M. The position accounts for 0.51% of the portfolio, ranked #59.

Argent Trust Company first reported a position in GILD in Q2 2013 and has held it in 10 quarters since. The position peaked at $1.37M in Q2 2015. 1,573 funds tracked by Wall St. Rank hold GILD as of Q3 2015.

Argent Trust Company held 11,597 shares of Gilead Sciences worth $1.14M as of Q3 2015.
Argent Trust Company sold 92 Gilead Sciences shares in Q3 2015, an estimated $10.2K.
Gilead Sciences made up 0.51% of Argent Trust Company's portfolio in Q3 2015, its #59 holding.
Argent Trust Company first reported a position in Gilead Sciences in Q2 2013 and has held it in 10 quarters since.
Argent Trust Company's Gilead Sciences position peaked at $1.37M in Q2 2015.
1,573 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2015.

Based on Argent Trust Company's 13F filing for Q3 2015, filed 13 Nov 2015.